[EN] FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST<br/>[FR] DÉRIVÉS D'URÉE CYCLIQUE FUSIONNÉS UTILISÉS COMME ANTAGONISTES DE CRHR2
申请人:RAQUALIA PHARMA INC
公开号:WO2019198692A1
公开(公告)日:2019-10-17
The present invention relates to fused cyclic urea derivatives which have antagonistic activities against CRHR1 and/or CRHR2, and which are useful in the treatment or prevention of disorders and diseases in which CRHR1 and/or CRHR2 is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CRHR1 and/or CRHR2 is involved.